Table 2.
Median Percent Change from Baseline SLE Biomarkers, Belimumab 10 mg/kg IV
| DNA Antibody | Complement C4 | CD20+ | |
|---|---|---|---|
| Adult22 (Furie)a | −49.5 | +51.9 | −54.8 |
| Adult23 (Navarra) | –37.6 | +30.4 | -- |
| Pediatric21 (Brunner) | −44.9 | +50 | −65.8 |
Biomarkers assessed at week 76, all others at week 52
IV, intravenous; SLE, systemic lupus erythematosus